Difference between revisions of "Male Pattern Baldness"

From WaiWiki
(PGD2)
(5-alpha-reductase and DHT)
Line 2: Line 2:
 
<blockquote>Male pattern baldness is caused by a genetic sensitivity of hair follicles to DHT. This hormone causes follicles to shrink or "miniaturize". In turn, this shortens their lifespan and prevents them from producing hair normally.</blockquote>
 
<blockquote>Male pattern baldness is caused by a genetic sensitivity of hair follicles to DHT. This hormone causes follicles to shrink or "miniaturize". In turn, this shortens their lifespan and prevents them from producing hair normally.</blockquote>
  
== 5-alpha-reductase and DHT ==
+
== 5-alpha-reductase ==
 +
5-alpha-reductase (5-AR) is an NADPH-dependent enzyme which converts testosterone to DHT. Three isoenzymes of 5 alpha-reductase enzyme are recognised
 +
* [http://en.wikipedia.org/wiki/SRD5A1 type 1] - which is located on the short arm of chromosome 7 and occurs in non genital skin, '''scalp''', in the sebaceous gland, in the liver and in the brain
 +
* [http://en.wikipedia.org/wiki/SRD5A2 type 2] - which is located on the short arm of chromosome 2 and occurs mainly in the prostate, genital skin, seminal vesicles and in the '''dermal papilla''' [http://www.ncbi.nlm.nih.gov/pubmed/15026079 Occhiato et al.]
 +
** testosterone has a much higher affinity for this type 2 than for type 1
 +
* type3 is also required for the glycosylation, it converts polyprenol to dolichol
 +
 
 
Men with androgenic alopecia typically have higher levels of 5-alpha-reductase, lower levels of total testosterone, higher levels of unbound/free testosterone, and higher levels of total free androgens including DHT.
 
Men with androgenic alopecia typically have higher levels of 5-alpha-reductase, lower levels of total testosterone, higher levels of unbound/free testosterone, and higher levels of total free androgens including DHT.
 +
 +
In 5 alpha-reductase deficiency (5-ARD), the ''type 2'' isoenzyme is that which is lacking. Men with this condition do not develop male-pattern baldness despite evidence that the type 1 isoenzyme is the dominant form in the adult male scalp, and in 5 alpha-reductase deficiency, this isoenzyme is present at normal levels. Thus, one must conclude that the '''type 2 5-AR is necessary to the development of male pattern baldness''' [http://www.gpnotebook.co.uk/simplepage.cfm?ID=1953169455 ref]. This conclusion doesn't sound justified, and dutasteride which inhibits type 1 too is more effective than finasteride which inhibits type 2.
 +
 +
=== What affects 5-AR? ===
 +
The only recognized, effective way for slowing down male pattern baldness is by inhibiting ''5-AR type 2'' via [http://en.wikipedia.org/wiki/Finasteride Finasteride] or similar drug. Therefore, it is important to have an overview on what inhibits or promotes 5-AR.
 +
 +
==== Inhibition ====
 +
* Synthetic drug [http://en.wikipedia.org/wiki/Finasteride Finasteride] inhibits type 2 and 3
 +
** 5 mg per day is able to reduce about 70% of the serum DHT concentration [http://www.ncbi.nlm.nih.gov/pubmed/15026079 Occhiato et al.]
 +
* Synthetic drug [http://en.wikipedia.org/wiki/Dutasteride Dutasteride] inhibits all types of 5-AR
 +
** Dutasteride is considered more effective at 0.1mg than Finasteride at 5mg doses, so it is possible that actually inhibiting ''type 1'' is more important than type 2
 +
** 90% reduction of serum DHT (dosage not mentioned)
 +
* [http://en.wikipedia.org/wiki/Alfatradiol Alfatradiol/Pantostin] is topical ethanolic solution that inhibits 5-AR when applied on the scalp. The ethanol can irritate the skin.
 +
** Minoxidil is more effective, but at least Alfatradiol decreases hair loss [http://www.ncbi.nlm.nih.gov/pubmed/17451383 Blume-Peytavi et al.]
 +
** No prescription is needed in Germany, so it's fairly safe, besides the possibility of skin irritation.
 +
 +
* ''Zinc sulphate and azelaic acid'' inhibit 5-AR in human skin ''in vitro''. Adding ''B6'' increases the effect of zinc. A combination of the three in low amounts achieved 90% inhibition of 5-AR. [http://www.ncbi.nlm.nih.gov/pubmed/3207614 Stamatiadis et al]
 +
* ''Saw palmetto and beta-sitosterol'' [http://www.ncbi.nlm.nih.gov/pubmed/12006122 Prager et al.]
 +
* ''Unsaturated fatty acids'' gamma-linolenic, alpha-linolenic, linoleic, and oleic acid [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1132824/ Liang and Liao]
 +
* ''Medium chain fatty acids'' found in coconut oil, palm kernel oil, as well as ''unsaturated'' alpha-linolenic and oleic [http://onlinelibrary.wiley.com/doi/10.1002/cbdv.200800125/abstract Liu et al.]
 +
* Various ''polyphenols'' [http://www.ncbi.nlm.nih.gov/pubmed/11931850 Hiipakka et al.]
 +
** Green tea catechin (-)-epigallocatechin gallate (EGCG) shows potent inhibition in cell-free but not in whole-cell assays of 5-AR
 +
** type 1 inhibitors: myricetin, quercitin, baicalein, and fisetin; alizarin, anthrarobin, gossypol, nordihydroguaiaretic acid, caffeic acid phenethyl ester, and octyl and dodecyl gallates
 +
** type 2 inhibitors: biochanin A, daidzein, genistein, and kaempferol
 +
* Cream containing ''honokiol'' [http://www.ncbi.nlm.nih.gov/pubmed/23049247 Bernard et al.]
 +
** [http://www.dreliaz.org/abstract/honokiol-research/ Collection] of research on honokiol, not necessarily related to hair loss
 +
* ''Ganoderic acid'' (in Reishi mushroom) [http://www.sciencedirect.com/science/article/pii/S0960894X0900287X Liu et al.]
 +
 +
 +
==== Promotion ====
 +
* 6-month dietary ''vitamin E (VE) deficiency'' in rats resulted in a twofold increase in the mRNA level of SRD5A1 gene and a twofold decrease in the mRNA level of GCLM gene [http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=7910314 Fischer et al.]
 +
* ''Hyperinsulinemia''
 +
** elevated levels of 5α-reduced androgens seen in hyperinsulinemic conditions might be explained on the basis of a stimulatory effect of insulin on 5α-reductase in granulosa cells. [http://www.ncbi.nlm.nih.gov/pubmed/20810561 Kayampilly et al.], [http://www.biolreprod.org/cgi/content/meeting_abstract/81/1_MeetingAbstracts/563 Another paper]
 +
** acutely enhances ACTH effects on both the androgen and glucocorticoid pathways that suggest insulin stimulation of 5 α-reductase activity [http://www.eje-online.org/content/164/2/197 Tosi et al.]
 +
* A diet only ''deficient in linoleate'' causes mild skin scaling and hair loss in mice [http://www.jlr.org/content/38/4/805.full.pdf+html Cunnane and Anderson] (note: not clear if it's due to 5-AR promotion, move to some other section)
  
 
== PGD2 ==
 
== PGD2 ==

Revision as of 14:14, 18 October 2012

What is male pattern baldness?

Male pattern baldness is caused by a genetic sensitivity of hair follicles to DHT. This hormone causes follicles to shrink or "miniaturize". In turn, this shortens their lifespan and prevents them from producing hair normally.

5-alpha-reductase

5-alpha-reductase (5-AR) is an NADPH-dependent enzyme which converts testosterone to DHT. Three isoenzymes of 5 alpha-reductase enzyme are recognised

  • type 1 - which is located on the short arm of chromosome 7 and occurs in non genital skin, scalp, in the sebaceous gland, in the liver and in the brain
  • type 2 - which is located on the short arm of chromosome 2 and occurs mainly in the prostate, genital skin, seminal vesicles and in the dermal papilla Occhiato et al.
    • testosterone has a much higher affinity for this type 2 than for type 1
  • type3 is also required for the glycosylation, it converts polyprenol to dolichol

Men with androgenic alopecia typically have higher levels of 5-alpha-reductase, lower levels of total testosterone, higher levels of unbound/free testosterone, and higher levels of total free androgens including DHT.

In 5 alpha-reductase deficiency (5-ARD), the type 2 isoenzyme is that which is lacking. Men with this condition do not develop male-pattern baldness despite evidence that the type 1 isoenzyme is the dominant form in the adult male scalp, and in 5 alpha-reductase deficiency, this isoenzyme is present at normal levels. Thus, one must conclude that the type 2 5-AR is necessary to the development of male pattern baldness ref. This conclusion doesn't sound justified, and dutasteride which inhibits type 1 too is more effective than finasteride which inhibits type 2.

What affects 5-AR?

The only recognized, effective way for slowing down male pattern baldness is by inhibiting 5-AR type 2 via Finasteride or similar drug. Therefore, it is important to have an overview on what inhibits or promotes 5-AR.

Inhibition

  • Synthetic drug Finasteride inhibits type 2 and 3
    • 5 mg per day is able to reduce about 70% of the serum DHT concentration Occhiato et al.
  • Synthetic drug Dutasteride inhibits all types of 5-AR
    • Dutasteride is considered more effective at 0.1mg than Finasteride at 5mg doses, so it is possible that actually inhibiting type 1 is more important than type 2
    • 90% reduction of serum DHT (dosage not mentioned)
  • Alfatradiol/Pantostin is topical ethanolic solution that inhibits 5-AR when applied on the scalp. The ethanol can irritate the skin.
    • Minoxidil is more effective, but at least Alfatradiol decreases hair loss Blume-Peytavi et al.
    • No prescription is needed in Germany, so it's fairly safe, besides the possibility of skin irritation.
  • Zinc sulphate and azelaic acid inhibit 5-AR in human skin in vitro. Adding B6 increases the effect of zinc. A combination of the three in low amounts achieved 90% inhibition of 5-AR. Stamatiadis et al
  • Saw palmetto and beta-sitosterol Prager et al.
  • Unsaturated fatty acids gamma-linolenic, alpha-linolenic, linoleic, and oleic acid Liang and Liao
  • Medium chain fatty acids found in coconut oil, palm kernel oil, as well as unsaturated alpha-linolenic and oleic Liu et al.
  • Various polyphenols Hiipakka et al.
    • Green tea catechin (-)-epigallocatechin gallate (EGCG) shows potent inhibition in cell-free but not in whole-cell assays of 5-AR
    • type 1 inhibitors: myricetin, quercitin, baicalein, and fisetin; alizarin, anthrarobin, gossypol, nordihydroguaiaretic acid, caffeic acid phenethyl ester, and octyl and dodecyl gallates
    • type 2 inhibitors: biochanin A, daidzein, genistein, and kaempferol
  • Cream containing honokiol Bernard et al.
    • Collection of research on honokiol, not necessarily related to hair loss
  • Ganoderic acid (in Reishi mushroom) Liu et al.


Promotion

  • 6-month dietary vitamin E (VE) deficiency in rats resulted in a twofold increase in the mRNA level of SRD5A1 gene and a twofold decrease in the mRNA level of GCLM gene Fischer et al.
  • Hyperinsulinemia
    • elevated levels of 5α-reduced androgens seen in hyperinsulinemic conditions might be explained on the basis of a stimulatory effect of insulin on 5α-reductase in granulosa cells. Kayampilly et al., Another paper
    • acutely enhances ACTH effects on both the androgen and glucocorticoid pathways that suggest insulin stimulation of 5 α-reductase activity Tosi et al.
  • A diet only deficient in linoleate causes mild skin scaling and hair loss in mice Cunnane and Anderson (note: not clear if it's due to 5-AR promotion, move to some other section)

PGD2

Recent research suggests that elevated levels of the enzyme prostaglandin D2 synthase and its product prostaglandin D2 (PGD2) in hair follicles causes androgenetic alopecia. [Garza A et al]

  • Prostaglandin D2 synthase (Prostaglandin-H2 D-isomerase (PTGDS) = H-PGDS) converts prostaglandin H2 (PGH2) into prostaglandin D2 (PGD2), so maybe a topical inhibitor of this enzyme will do the trick (to compensate for the elevated level of this enzyme).
    • HQL-79 is a well known, but relatively weak H-PGDS inhibitor. [Aritake K et al]
    • Scientists seem to have designed much more potent H-PGDS inhibitors. [Kamauchi S et al]
    • More H-PGDS inhibitors here, but no formulae are provided "The formulae of the inhibitors are proprietary information"[Takahashi S et al]
    • TFC-007 is a selective H-PGDS inhibitor. [Nabe T et al]
  • H-PGDS levels also seem to decrease rapidly (through the ubiquitin-proteasome system) when intracellular calcium is increased [Yazaki M et al] [Free full text]
    • but (the required) calcium ionophores (to increase intracellular calcium locally) also seem to promote tumors. [Kumar S et al]